Fred P. Lampropoulos - 26 Feb 2022 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
26 Feb 2022
Net transactions value
-$509,315
Form type
4
Filing time
01 Mar 2022, 19:01:25 UTC
Previous filing
10 Sep 2021
Next filing
12 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +17,680 +1.8% $0.000000 985,596 26 Feb 2022 Direct F1
transaction MMSI Common Stock, No Par Value Tax liability $509,315 -7,832 -0.79% $65.03 977,764 28 Feb 2022 Direct
holding MMSI Common Stock, No Par Value 96,357 26 Feb 2022 By 401(k) Plan F2
holding MMSI Common Stock, No Par Value 3,859 26 Feb 2022 By spouse
holding MMSI Common Stock, No Par Value 90 26 Feb 2022 By spouse as custodian for child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Award $0 +48,566 $0.000000 48,566 26 Feb 2022 Common Stock 48,566 $65.03 Direct F3
holding MMSI Non-qualified stock options (right to buy) 50,000 26 Feb 2022 Common Stock 50,000 $16.05 Direct F4
holding MMSI Non-qualified stock options (right to buy) 6,000 26 Feb 2022 Common Stock 6,000 $16.05 See footnote F5
holding MMSI Non-qualified stock options (right to buy) 200,000 26 Feb 2022 Common Stock 200,000 $28.20 Direct F6
holding MMSI Non-qualified stock options (right to buy) 6,000 26 Feb 2022 Common Stock 6,000 $28.20 See footnote F7
holding MMSI Non-qualified stock options (right to buy) 38,002 26 Feb 2022 Common Stock 38,002 $44.80 Direct F8
holding MMSI Non-qualified stock options (right to buy) 4,000 26 Feb 2022 Common Stock 4,000 $44.80 See footnote F9
holding MMSI Non-qualified stock options (right to buy) 159,151 26 Feb 2022 Common Stock 159,151 $55.73 Direct F10
holding MMSI Non-qualified stock options (right to buy) 2,000 26 Feb 2022 Common Stock 2,000 $55.73 See footnote F11
holding MMSI Non-qualified stock options (right to buy) 100,334 26 Feb 2022 Common Stock 100,334 $37.71 Direct F12
holding MMSI Non-qualified stock options (right to buy) 58,083 26 Feb 2022 Common Stock 58,083 $56.25 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee and Board of Directors that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02/26/2020.
F2 Represents plan holdings as of 02/28/2022.
F3 Becomes exercisable in equal annual installments of 25% commencing 2/28/2023.
F4 Became exercisable in equal annual installments of 20% commencing 1/28/2017.
F5 Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited.
F6 Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
F7 Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
F8 Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
F9 Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
F10 Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
F11 Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
F12 Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
F13 Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.